Sex hormones affect the calcium signaling response of human arterial cells to LDL

Journal of Surgical Research

Volumn 63, Issue 1, 1996, Pages 64-72

  Wells, Kip E ^a   Miguel, Remedios ^a   Alexander, J Jeffrey ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; ESTRADIOL; FURA 2 ACETOXYMETHYL ESTER; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SEX HORMONE; TESTOSTERONE;

AORTA MEDIA; ATHEROGENESIS; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL PROTECTION; CELL VIABILITY; CHROMIUM 51 RELEASE; CONFERENCE PAPER; CONTROLLED STUDY; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPECTROFLUOROMETRY; VASCULAR SMOOTH MUSCLE;

EID: 0029936088     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0224     Document Type: Conference Paper

References (40)

1. Knopp, R. H. The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease. Obstet. Gynecol. 72: 23S, 1988.
2. Adams, M. R., Kaplan, J. R., Manuck, S. B., et al. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Arteriosclerosis 10: 1051, 1990.
3. Stampfer, M. J., Willett, W. C., Colditz, G. A., Rosner, B., Speizer, F. E., and Hennekens, C. H. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N. Engl. J. Med. 313: 1044, 1985.
4. Barrett-Connor, E., Wingard, D. L., and Criqui, M. H. Post-menopausal estrogen use and heart disease. Risk factors in the 1980's. JAMA 261: 2095, 1989.
5. Tischer-Dzoga, K., Wissler, R. W., and Vesselinovitch, D. The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipidemic serum. Exp. Mol. Pathol. 39: 355, 1983.
6. Fischer, G. M., Cherian, K., and Swain, M. L. Increased synthesis of aortic collagen and elastin in experimental atherosclerosis. Inhibition by contraceptive steroids. Atherosclerosis 39:463, 1981.
7. Hough, J. L., and Zilversmit, D. B. Effect of 17 beta estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis 6: 57, 1986.
8. Mitchell, H. C. Effect of estrogens and progestogen on platelet adhesiveness and aggregation in rabbits. J. Lab. Clin. Med. 83: 79, 1974.
9. Chang, W. C., Nakao, J., Orimo, H., and Murata, S. I. Stimulation of prostacydin biosynthetic activity by estradiol in rat aortic smooth muscle cells in culture. Biochim. Biophys. Acta. 619: 107, 1980.
10. Subbiah, M. T., Kessel, B., Agrawal, M., Rajan, R., Abplanalp, W., and Rymaszewski, Z. Antioxidant potential of specific estrogens on lipid peroxidation. J. Clin. Endocrinol. Metab. 77: 1095, 1993.
11. Maziere, C., Auclair, M., Ronveaux, M. F., Salmon, S., Santus, R., and Maziere, J. C. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis 89: 175, 1991.
12. Smirnov, V. N., Voyno-Yasenetskaya, T. A., Antonov, A. S., et al. Vascular signal transduction and atherosclerosis. Ann. N.Y. Acad. Sci. 598: 167, 1990.
13. Rasmussen, H. The cycling of calcium as an intracellular messenger. Sci. Am. 261: 66, 1989.
14. Sachinidis, A., Mengden, T., Locher, R., Brunner, C., and Vetter, W. Novel cellular activities for low density lipoprotein in vascular smooth muscle cells. Hypertension 15: 704, 1990.
15. Weisser, B., Locher, R., Mengden, T., and Vetter, W. Oxidation of low density lipoprotein enhances its potential to increase intracellular free calcium concentration in vascular smooth muscle cells. Arterioscler. Thromb. 12: 231, 1992.
16. Henry, P. O. Atherogenesis, calcium and calcium antagonists. Am. J. Cardiol. 66: 31, 1990.
17. Orimo, H., and Ouchi, Y. The role of calcium and magnesium in the development of atherosclerosis. Experimental and clinical evidence. Ann. NY Acad. Sci. 58: 444, 1990.
18. 2+ channel blockers. Atherosclerosis 88: 109, 1991.
19. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 760: 3440, 1985.
20. 3H-adenine and lactate dehydrogenase. J. Lab. Clin. Med. 106: 253, 1985.
21. Seed, M., and Crook, D. Post-menopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins. Curr. Opin. Lipidol. 5: 48, 1994.
22. Ross, P. K., Paganini-Hill, A., Mack, T. M., Arthur, M., and Henderson, B. E. Menopausal estrogen therapy and protection from death from ischemic heart disease. Lancet 1: 858, 1981.
23. Sacks, F. M., and Walsh, B. W. Sex hormones and lipoprotein metabolism. Curr. Opin. Lipidol. 5: 236, 1994.
24. Walsh, B. W., Schiff, I., Rosner, B., Greenberg, L., Ravnikar, V., and Sacks, F. M. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N. Engl. J. Med. 325: 1196, 1991.
25. Krauss, R. M., Perlman, J. A., Ray, R., and Petitti, D. Effects of estrogen dose and smoking on lipid and lipoprotein levels in postmenopausal women. Am. J. Obstet. Gynecol. 158: 1606, 1988.
26. Exton, J. H. Calcium signalling in cells-molecular mechanisms. Kidney Int. 32: 685, 1987.
27. Galizzi, J. P., Qar, J., Fossett, M., Van Renterghem, C., and Lazdunski, M. Regulation of calcium channels in aortic smooth muscle cells by protein kinase C activators (diacylglycerol and phorbol esters) and by peptides (Vasopressin and bombesin) that stimulate phosphoinosititide breakdown. J. Biol. Chem. 262: 6947, 1987.
28. Wang, K. K., Du, Y. S., Diglio, C., Tsang, W., and Kuo, T. H. Hormone-induced phosphorylation of the plasma membrane calcium pump in cultured aortic endothelial cells. Arch. Biochem. Biophys. 289: 103, 1991.
29. Lynch, J. J., Ferro, T. J., Blumenstock, F. A., Brockenauer, A. M., and Malik, A. B. Increased endothelial albumin permeability mediated by protein kinase C activation. J. Clin. Invest. 85: 1991, 1990.
30. Oliver, J. A. Adenylate cyclase and protein kinase C mediate opposite actions on endothelial junctions. J. Cell Physiol. 145: 536, 1990.
31. Yamada, Y., Furumichi, T., Furui, H., et al. Roles of calcium, cyclic nucleotides and protein kinase C on regulation of endothelial permeability. Arteriosclerosis 10: 410, 1990.
32. Strickberger, S. A., Russek, L. N., and Phair, R. D. Evidence for increased aortic plasma membrane transport caused by experimental atherosclerosis in rabbits. Circ. Res. 62: 75, 1988.
33. Resink, T. J., Rybin, V., Bernhardt, J., Orlov, S., Buhler, F. R., and Tkachuk, V. A. Cellular signalling by lipoproteins in cultured smooth muscle cells from spontaneously hypertensive rats. J. Vasc. Res. 30: 169, 1993.
34. 2+ via pertussis toxin-sensitive GTP-binding protein in vascular smooth muscle cells. Biochem Int. 18: 647, 1989.
35. i in vascular smooth muscle cells. Circ. Res. 73: 118, 1993.
36. Sachinidis, A., Locher, R., and Vetter, W. Generation of intracellular signals by low density lipoprotein is independent of the classical LDL receptor. Am. J. Hypertens. 4: 274, 1991.
37. Negre-Salvayre, A., Fitoussi, G., Reaud, V., Pieraggi, M. T., Thiers, J. C., and Salvayre, R. A delayed and sustained rise of cytosolic calcium is elicited by oxidized LDL in cultured bovine aortic endothelial cells. FEBS Lett. 299: 60, 1992.
38. +2 Channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells. Br. J. Pharmacol. 107: 738, 1992.
39. Weinstein, D. B., and Heider, J. G. Antiatherogenic properties of calcium antagonists. Am. J. Cardiol. 59: 163B, 1987.
40. Jackson, C. L., Bush, R. C., Bowyer, D. E. Mechanisms of antiatherogenic action of calcium antagonists. Atherosclerosis 80: 17, 1989.